Comparing Vraylar vs Abilify
| Vraylar (cariprazine) | Abilify (aripiprazole) |
|
|---|
| Vraylar (cariprazine) | Abilify (aripiprazole) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar I disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to... View more |
Prescription only
Abilify is an antipsychotic used to treat schizophrenia, manic and mixed episodes associated with Bipolar disorder, Tourette's Disorder, irritability associated with Autistic disorder, or for the... View more |
Related suggestions Bipolar Disorder
Major Depressive Disorder
Schizophrenia
|
|||||||||||||||
| More about Vraylar (cariprazine) | More about Abilify (aripiprazole) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Vraylar has an average rating of 6.1 out of 10 from a total of 520 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 32% reported a negative effect. |
Abilify has an average rating of 6.1 out of 10 from a total of 1187 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Vraylar side effects |
View all Abilify side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Vraylar prices |
View all Abilify prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other aripiprazole brands include: Abilify Asimtufii, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio, Opipza | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
504 hours |
146 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 576 drugs are known to interact with Vraylar:
|
A total of 731 drugs are known to interact with Abilify:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 17, 2015 |
November 15, 2002 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.